Status:
COMPLETED
Drug Use Investigation for XYZAL®
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Perennial and Seasonal
Eligibility:
All Genders
Brief Summary
This post-marketing surveillance study (PMS) is conducted to collect safety and efficacy data among subjects with allergic rhinitis, urticaria, eczema, dermatitis, skin irritation, prurigo or pruritus...
Eligibility Criteria
Inclusion
- Must be the first time for taking levocetirizine tablet
Exclusion
- As this is PMS study, there are no exclusion criteria.
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
10728 Patients enrolled
Trial Details
Trial ID
NCT01445262
Start Date
February 1 2011
End Date
December 1 2013
Last Update
August 13 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.